ZNF736P9Y

Across TCGA pan-cancer cohorts, ZNF736P9Y RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of ZNF736P9Y’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF736P9Y RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF736P9Y is over-expressed in tumor, although a few such as KICH and PRAD show the opposite, repressed pattern.

KIRC, BLCA, and LUSC are the cancer types where ZNF736P9Y tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF736P9Y RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.569	<.001	8	view →
BLCA	Male	All	+1.627	.008	6	view →
LUSC	Male	All	+0.821	<.001	5	view →
COAD	Male	All	+0.889	.004	4	view →
LUAD	Male	All	+0.276	.012	3	view →
KICH	Male	All	−0.214	.027	2	view →
PRAD	All	All	−0.140	<.001	2	view →
THCA	Male	All	+0.068	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

ZNF736P9Y–KIRC

Open the KIRC breakdown →